The Spiez Laboratory will be the first facility to be part of the WHO’s BioHub system, an infrastructure that will facilitate the timely sharing

  Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sciences entrepreneurs.

A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 million Series C financing round. Headquartered

Swiss biotech companies Berna Biotech Pharma and Swiss Biotech Center are joining forces to develop a second-generation vaccine against covid-19. The goal is to conduct

  Swedish biopharmaceutical group Ferring Pharmaceuticals has opened a state-of-the-art innovation center at Biopôle, adding a new hub for biologics research and development to the

  Vaud-based MedAlliance has raised over USD 50 Million in equity funding for its novel balloon that provides a controlled sustained release of a limus

  The EPFL Innovation Park and Groupe Mutuel are joining forces to launch Tech4Eva, the first start-up acceleration program in Switzerland addressing women’s health.  

Scientists at the University of Bern and Inselspital have established organoid culture models from prostate tumor biopsies. These are small clusters of cells which can

  As part of the Horizon 2020 research program, the European project BIGPICTURE, to which the HES-SO Valais-Wallis is contributing, aims to build the world’s

After a particularly challenging year for hospitals, the prestigious U.S. magazine Newsweek has once again included the Lausanne University Hospital (CHUV) in its list of

Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and neck cancer treatment drug.

  An international team involving researchers from the Institute of Virology and Immunology (IVI) of the Federal Food Safety and Veterinary Office BLV and the

Biopôle SA continues its expansion with the construction of three new buildings. By 2024, an additional 23’000 square meters of office and laboratory space will

  Biel-based medtech company Optimo Medical has sealed a partnership with Ansys, a global 1.516 billion revenue company providing multiphysics engineering simulation software since 1970.

With the support of the Touring Club Switzerland, an endowed professorship in emergency telemedicine was appointed at the University of Bern, aiming to create the

Using a special gas treatment, the Fribourg-based company Medistri suppresses all germs contained in the vials destined to receive the Covid-19 vaccine. The company expects

With the foundation of the Multidisciplinary Center for Infectious Diseases and Immunity, the University of Bern will be able to study the societal, economic and

With the support of the Touring Club Switzerland, an endowed professorship in emergency telemedicine was appointed at the University of Bern, aiming to create the

Researchers from EPFL have invented a technique to navigate electronic devices that are smaller than human hair inside blood vessels and reach arterioles. The next

With the launch of its CE-Mark certified device cSOFA, which assesses the severity of Covid-19 among patients within only five minutes of analyzing a blood

With the foundation of the Multidisciplinary Center for Infectious Diseases and Immunity, the University of Bern will be able to study the societal, economic and

Valued at CHF 86 million and scheduled to be operational in 2024, the Pôle Santé campus aims to be a platform for the exchange of

The Swiss Integrative Center for Human Health (SICHH) and EIKON, Fribourg’s Vocational School of Applied Arts, have launched a new scientific communication platform called “Connect

Ypsomed has developed the world’s first zero carbon emission prefilled autoinjector. The new YpsoMate Zero uses alternative biopolymers and a novel packaging design that follows

Lonza’s new building dedicated to the manufacturing of Moderna’s Covid-19 vaccine will be operational starting December 2020. 300 million doses will be produced annually at

Global leader in data-driven medicine SOPHiA GENETICS has closed a $110 million financing round to enter the next stage of its expansion, with a focus

Rheon Medical is revolutionizing glaucoma treatment with its eyeWatch system, in which Coat-X’s coating technology plays a central role. Both start-ups were awarded prizes at